Singapore, Feb 19, 2010: Hard to Treat Diseases (HTDS) and its China subsidiary Mellow Hope announced that it has shipped the first lot of H1N1 Vaccine worth $1 million to Chile.

Hard to Treat Diseases endured a lengthy regulatory approval for the H1N1 vaccine's export, but since the company established the export channel, HTDS doesn't expect any further setbacks with H1N1 vaccine exports to Chile.

Mr Terry Yuan, CEO, HTDS said, "We encountered some routine complications with getting the shipping and import permits in order. These complications stalled our effort to ship our H1N1 vaccine ASAP. It's all taken care of now, we opened the channels and can schedule routine shipments of our H1N1 vaccine for Chile. This contract has been in the works for months. We were expecting to have shipped this order back in November - December 2009 however it took several additional months to clear all legal and administrative hurdles. In a medical industry this is the norm. We work hard to get our orders filled and secure more contracts with other countries, from which we've received previous inquiries about our H1N1 vaccine. Gaining government permissions often stretches, but that doesn't stop our success, or determination."